Abstract
Of the four categories of prostatitis, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is the most prevalent. CP/CPPS is also the form of prostatitis that has been most associated with andrologic sequelae. These complications include decreased testosterone, erectile dysfunction, painful ejaculation, and premature ejaculation. The prevalence of these symptoms in patients with CP/CPPS is high and plays a significant role in the morbidity of patients. As such, a sexual function assessment is an important part of evaluating any patient with pelvic or perineal pain. Treatment strategies that have addressed sexual dysfunction include testosterone replacement therapy, alpha-adrenergic blockers, and PDE5s. This chapter will discuss the association of prostatitis with endocrine abnormalities and sexual dysfunction, with a focus on pathophysiology and treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yunda IF, Imshinetskaya LP (1977) Testosterone excretion in chronic prostatitis. Andrologia 9:89–94
Pontari MA, Ruggieri MR (2004) Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol 172:839–845
Jia Y, Liu X, Yan J et al (2015) The alteration of inflammatory markers and apoptosis on chronic prostatitis induced by estrogen and androgen. Int Urol Nephrol 47:39–46
Meng J, Mostaghel EA, Vakar-Lopez F et al (2011) Testosterone regulates tight junction proteins and influences prostatic autoimmune responses. Horm Cancer 2:145–156
Pang R, Lu J, Zhou X et al (2015) MP25-02 testosterone replacement therapy for hypogonadal patients with chronic prostatitis/chronic pelvic pain syndrome. J Urol 193, e285
Tuncel A, Akbulut Z, Atan A et al (2006) Common symptoms in men with prostatic inflammation. Int Urol Nephrol 38:583–586
Liang C-Z, Zhang X-J, Hao Z-Y et al (2004) Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. BJU Int 93:568–570
Gonen M, Kalkan M, Cenker A et al (2005) Prevalence of premature ejaculation in Turkish men with chronic pelvic pain syndrome. J Androl 26:601–603
Lee SWH, Liong ML, Yuen KH et al (2008) Adverse impact of sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. Urology 71:79–84
Trinchieri A, Magri V, Cariani L et al (2007) Prevalence of sexual dysfunction in men with chronic prostatitis/chronic pelvic pain syndrome. Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol Assoc Ric Urol 79:67–70
Shoskes DA (2012) The challenge of erectile dysfunction in the man with chronic prostatitis/chronic pelvic pain syndrome. Curr Urol Rep 13:263–267
Hao Z-Y, Li H-J, Wang Z-P et al (2011) The prevalence of erectile dysfunction and its relation to chronic prostatitis in Chinese men. J Androl 32:496–501
Chung S-D, Keller JJ, Lin H-C (2012) A case-control study on the association between chronic prostatitis/chronic pelvic pain syndrome and erectile dysfunction. BJU Int 110:726–730
Guay AT (2006) Testosterone and erectile physiology. Aging Male: Off J Int Soc Study Aging Male 9:201–206
Shoskes DA, Prots D, Karns J et al (2011) Greater endothelial dysfunction and arterial stiffness in men with chronic prostatitis/chronic pelvic pain syndrome--a possible link to cardiovascular disease. J Urol 186:907–910
Shoskes DA, Berger R, Elmi A et al (2008) Muscle tenderness in men with chronic prostatitis/chronic pelvic pain syndrome: the chronic prostatitis cohort study. J Urol 179:556–560
Screponi E, Carosa E, Di Stasi SM et al (2001) Prevalence of chronic prostatitis in men with premature ejaculation. Urology 58:198–202
Mo M-Q, Long L-L, Xie W-L et al (2014) Sexual dysfunctions and psychological disorders associated with type IIIa chronic prostatitis: a clinical survey in China. Int Urol Nephrol 46:2255–2261
Delavierre D, Sibert L, Rigaud J et al (2014) Painful ejaculation. Prog En Urol J Assoc Fr Urol Société Fr Urol 24:414–420
Tran CN, Shoskes DA (2013) Sexual dysfunction in chronic prostatitis/chronic pelvic pain syndrome. World J Urol 31:741–746
Nickel JC, Elhilali M, Emberton M et al (2006) The beneficial effect of alfuzosin 10 mg once daily in “real-life” practice on lower urinary tract symptoms (LUTS), quality of life and sexual dysfunction in men with LUTS and painful ejaculation. BJU Int 97:1242–1246
Grimsley SJS, Khan MH, Jones GE (2007) Mechanism of phosphodiesterase 5 inhibitor relief of prostatitis symptoms. Med Hypotheses 69:25–26
Kong DH, Yun CJ, Park HJ et al (2014) The efficacy of mirodenafil for chronic prostatitis/chronic pelvic pain syndrome in middle-aged males. World J Mens Health 32:145–150
Cantoro U, Catanzariti F, Lacetera V et al (2013) Comparison of tamsulosin vs tamsulosin/sildenafil effectiveness in the treatment of erectile dysfunction in patients affected by type III chronic prostatitis. Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol Assoc Ric Urol 85:109–112
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Syed, J., Mouraviev, V. (2016). Andrologic Sequelae in Prostatitis Patients. In: Cai, T., Bjerklund Johansen, T. (eds) Prostatitis and Its Management. Springer, Cham. https://doi.org/10.1007/978-3-319-25175-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-25175-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-25173-8
Online ISBN: 978-3-319-25175-2
eBook Packages: MedicineMedicine (R0)